Abstract:Background/aim: Tuberous sclerosis complex (TSC) is a multi-system syndrome caused by loss-of-function mutation in TSC1 or TSC2. Most TSC patients present with cardiac rhabdomyoma or cortical tubers during fetal life, and the symptoms are not uniform as their age. The gene products of TSC1/2 are components of the TSC protein complex and are important role in the PI3K/AKT/mTOR (PAM) signaling pathway. Based on three members of a family with variable expressivity, the purpose of this study was to clarify the clinical features of TSC in different age groups and to analyze the genetic characteristics of TSC2 gene. Methods: Clinical exome sequencing and co-segregation were used to identify a three-generation family with four affected individuals. HEK-293T cell model was constructed for subsequent experiments. Quantitative RT-PCR, western blotting, and subcellular localization were used to analyze the expression effect of TSC2 mutation. CCK-8 assay, wound healing assay, and cell cycle analysis were used to analyze the function effect of TSC2 mutation. Result: We identified a TSC family with heterozygous deletion of exon 4 in TSC2 by clinical exon sequencing. Sanger sequencing indicated that the affected individuals have 2541-bp deletion that encompassed exon 4 and adjacent introns. Deletion of exon 4 decreased the TSC2 mRNA and protein levels in HEK-293T cells, and activated the PI3K/AKT/mTOR pathway, thereby altering the cell cycle and promoting cell proliferation and migration. Conclusion: We confirmed the pathogenicity of the large deletion in TSC2 in a three- generations family.. Deletion of exon 4 of TSC2 affected cell proliferation, migration, and cell cycle via abnormal activation of the PAM pathway. This study evaluated the pathogenic effect of deletion of exon 4 of TSC2 and investigated the underlying mechanism.

TSC1 is Critical for Inkt-Cell Terminal Maturation and Controls Inkt-1/17 Balance (IRM7P.490)

iNKT cells require TSC1 for terminal maturation and effector lineage fate decisions.

Amendment history : Corrigendum ( April 2018 ) Expression of Concern ( November 2017 ) iNKT cells require TSC 1 for terminal maturation and effector lineage fate decisions

Tuberous sclerosis 1 promotes invariant NKT cell anergy and inhibits invariant NKT cell-mediated antitumor immunity.

Tsc1 Promotes B Cell Maturation but is Dispensable for Germinal Center Formation

TSC 1 Regulates the Balance Between Effector and Regulatory T Cells

Critical Role of the Tumor Suppressor Tuberous Sclerosis Complex 1 in Dendritic Cell Activation of CD4 T Cells by Promoting MHC Class II Expression Via IRF4 and CIITA.

TSC1/2 signaling complex is essential for peripheral naïve CD8+ T cell survival and homeostasis in mice.

Tumor Suppressor TSC1 is Critical for T-cell Anergy

Tsc1/2 Signaling Complex Is Essential For Peripheral Naive Cd8(+) T Cell Survival And Homeostasis In Mice

Role of Tumor Suppressor TSC1 in Regulating Antigen-Specific Primary and Memory CD8 T Cell Responses to Bacterial Infection

Disruption of Tsc1/2 Signaling Complex Reveals A Checkpoint Governing Thymic Cd4(+)Cd25(+)Foxp3(+), Regulatory T-Cell Development in Mice

Loss of TSC1/TSC2 sensitizes immune checkpoint blockade in non–small cell lung cancer

Tuberous Sclerosis 1 (Tsc1)-Dependent Metabolic Checkpoint Controls Development of Dendritic Cells

TSC1 controls macrophage polarization to prevent inflammatory disease

Signal Control of Inkt Development and Effector Lineage Differentiation (P1208)

A large deletion in TSC2 causes tuberous sclerosis complex by dysregulating PI3K/AKT/mTOR signaling pathway

TSC1-mTOR-controlled Metabolic Epigenetic Crosstalk Underlies DC Control of CD8+T Cell Homeostasis

TSC1/TSC2 Inactivation Inhibits AKT Through Mtorc1-Dependent Up-Regulation of STAT3-PTEN Cascade.

NK cell development requires Tsc1-dependent negative regulation of IL-15-triggered mTORC1 activation

TSC1/TSC2 Heterodimer and Its Role in Cell Growth Regulation